DARPA starts blood manufacturing project

06/12/2007 | United Press International

The Defense Advanced Research Projects Agency hopes to grow Type O negative blood outside of the body to help limit combat deaths, many of which occur due to blood loss. The program seeks to develop an automated progenitor cell-based culture system to create normal red blood cells. The group also will look for ways to extend the shelf life of blood donations.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX